The new generic products which were recently developed. Volunteer will receive a single dose of 1 tablet of Levonorgestrel 1.5 mg tablets of either test or reference with 250 mL of drinking water.,The
Sponsors
Bio-innova Co., Ltd.
Conditions
Healthy subjects
Bioequivalence Levonorgestrel 1.5 mg
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Levonorgestrel 1.5 mg tablets relative to Postinor 1 in healthy Thai female volunteers under fasting condition
TCTR20220926004
Start: 2022-12-22Target: 26Updated: 2026-08-03
Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Levonorgestrel Tablets (1.5 mg) relative to ESCAPELLE Tablet 1.5 mg in healthy Thai female volunteers under fasting condition
TCTR20221018006
Start: 2023-04-06Target: 26Updated: 2026-08-03